3545 results for «209»

Filter By

3545 results

Rapid-Fire - Tricuspid TEER

25 Nov 2024 – From PCR London Valves 2024

Discover a rapid-fire session showcasing selected PCR London Valves 2024 clinical cases focused on Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER). Explore a range of complications and innovative solutions, such as cardiogenic shock, single leaflet device attachment, and increased transvalvular gradients. Gain valuable insights into the challenges and...

Rapid-Fire - Tricuspid TEER

Mind the gap! - What's missing in the field of transcatheter valve interventions

25 Nov 2024 – From PCR London Valves 2024

Explore the key requirements for broadly adopting Transcatheter Mitral Valve Repair (TMVR), examine the challenges of Left Ventricular Outflow Tract Obstruction in Mitral Valve Replacement (MVR), and identify the additional tools needed for effective mitral valve repair. This session will provide a comprehensive assessment of the...

Mind the gap! - What's missing in the field of transcatheter valve interventions

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation
Didn’t find what you were looking for?